Skip to content. | Skip to navigation

National Cancer Institute U.S. National Institutes of Health www.cancer.gov

Navigation

Personal tools

You are here: Home / Biomarkers / FSTL1

FSTL1

Basics

Aliases:
This biomarker is also known as:
  • FLJ50214,
  • FSL1,
  • Follistatin-related protein 1,
  • Follistatin-like protein 1,
  • FRP,
  • follistatin-like 1,
  • FLJ52277,

View in BioMuta

Description…

FSTL1, a protein similar to follistatin, an activin-binding protein, contains an FS module, a follistatin-like sequence containing 10 conserved cysteine residues. It may modulate the action of some growth factors on cell proliferation and differentiation. There is evidence that FSTL1 binds heparin. FSTL1, overexpressed in synovial tissues from rheumatoid arthritis, is thought to be an autoantigen associated with the disease.

Attributes

QA State: Under Review
Type: Protein
Short Name:
HGNC Name: FSTL1

Datasets

There are no datasets associated with this biomarker.

Organs

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Studies

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Publications

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Resources

This biomarker is currently being annotated or is under review. You must be logged in or do not have permission to view any additional information. Contact Heather Kincaid at heather.kincaid@jpl.nasa.gov if you should have access to this biomarker.

Announcement 10/07/2014

EDRN Patient Advocates will host an EDRN Advocacy Educational Webinar, Biomarkers for Prostate Cancer Detection and Monitoring, on Monday, January 12th, 2015, at 1 p.m. EDT / 10 a.m. PDT. Registration is not required for this. Please click for more information.
Announcement 09/14/2014

Thank you to everyone who helped make the 9th EDRN Scientific Workshop a success. We look forward to seeing everyone at the 28th EDRN Steering Committee Meeting from March 31-April 2, 2015, in Atlanta, GA.